Loading…
Low-Dose Vasopressin in the Treatment of Septic Shock in Sheep
After induction of cecal perforation, 20 anesthetized sheep were randomized to be treated, when arterial blood pressure fell below 75 mm Hg, with vasopressin (fixed dose of 0.02 U/minute), norepinephrine (0.5-5 microg/kg/minute titrated to maintain mean arterial pressure between 75 and 85 mm Hg), va...
Saved in:
Published in: | American journal of respiratory and critical care medicine 2003-08, Vol.168 (4), p.481-486 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c358t-dfdc0f1d48234dcc59195d81649d0b340ce114208fad08551be680845918f6c3 |
---|---|
cites | cdi_FETCH-LOGICAL-c358t-dfdc0f1d48234dcc59195d81649d0b340ce114208fad08551be680845918f6c3 |
container_end_page | 486 |
container_issue | 4 |
container_start_page | 481 |
container_title | American journal of respiratory and critical care medicine |
container_volume | 168 |
creator | Sun, Qinghua Dimopoulos, George Nguyen, Duc Nam Tu, Zizhi Nagy, Nathalie Hoang, Anh Dung Rogiers, Peter De Backer, Daniel Vincent, Jean-Louis |
description | After induction of cecal perforation, 20 anesthetized sheep were randomized to be treated, when arterial blood pressure fell below 75 mm Hg, with vasopressin (fixed dose of 0.02 U/minute), norepinephrine (0.5-5 microg/kg/minute titrated to maintain mean arterial pressure between 75 and 85 mm Hg), vasopressin + norepinephrine (vasopressin at fixed dose 0.01 U/minute plus norepinephrine titrated as for norepinephrine only group), or no vasopressor (Ringer's lactate [control]). Mean arterial pressure was well maintained in all treatment groups. Superior mesenteric arterial blood flow was significantly lower in the vasopressin + norepinephrine group than in the vasopressin group. Vasopressin alone or combined with norepinephrine limited the increase in blood lactate concentration and ileal PCO2-gap compared with control and norepinephrine groups. Urine output was higher in the vasopressin group than in control and norepinephrine groups. Survival time was longer in the vasopressin (30 +/- 6 hours) and vasopressin + norepinephrine (30 +/- 3 hours) groups than in the norepinephrine group (20 +/- 1 hours, p < 0.05) and in all treatment groups than in the control group (17 +/- 2 hours, p < 0.05). Tissue injury was less severe in the vasopressin and vasopressin + norepinephrine groups than in the others. In this clinically relevant model of septic shock due to peritonitis, vasopressin administration (alone or with norepinephrine) can prolong survival. |
doi_str_mv | 10.1164/rccm.200205-447OC |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73552444</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>389399941</sourcerecordid><originalsourceid>FETCH-LOGICAL-c358t-dfdc0f1d48234dcc59195d81649d0b340ce114208fad08551be680845918f6c3</originalsourceid><addsrcrecordid>eNpdkF1LwzAUhoMobn78AG-keCF40ZnTJG16I8j8hMEuNsS70KWntrNtatIx_PdmdiAIgSTkOW_OeQi5ADoBiPmt1bqZRJRGVIScJ_PpARmDYP6SJvTQn2nC_EP6PiInzq0phUgCPSYjiJIURCLH5G5mtuGDcRi8Zc50Fp2r2sCvvsRgaTHrG2z7wBTBAru-0sGiNPpzByxKxO6MHBVZ7fB8v5-S5dPjcvoSzubPr9P7WaiZkH2YF7mmBeRcRoznWosUUpFLP0Oa0xXjVCMAj6gsspxKIWCFsaSSe04WsWan5HqI7az52qDrVVM5jXWdtWg2TiVMiIhz7sGrf-DabGzrW1OQprH_lcUeggHS1jhnsVCdrZrMfiugaidW7cSqQaz6FetrLvfBm1WD-V_F3qQHbgagrD7KbWVRuSara4-Dyta7QIil4opLYD8t9IDC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>199619536</pqid></control><display><type>article</type><title>Low-Dose Vasopressin in the Treatment of Septic Shock in Sheep</title><source>Freely Accessible Science Journals - May need to register for free articles</source><source>EZB Electronic Journals Library</source><creator>Sun, Qinghua ; Dimopoulos, George ; Nguyen, Duc Nam ; Tu, Zizhi ; Nagy, Nathalie ; Hoang, Anh Dung ; Rogiers, Peter ; De Backer, Daniel ; Vincent, Jean-Louis</creator><creatorcontrib>Sun, Qinghua ; Dimopoulos, George ; Nguyen, Duc Nam ; Tu, Zizhi ; Nagy, Nathalie ; Hoang, Anh Dung ; Rogiers, Peter ; De Backer, Daniel ; Vincent, Jean-Louis</creatorcontrib><description>After induction of cecal perforation, 20 anesthetized sheep were randomized to be treated, when arterial blood pressure fell below 75 mm Hg, with vasopressin (fixed dose of 0.02 U/minute), norepinephrine (0.5-5 microg/kg/minute titrated to maintain mean arterial pressure between 75 and 85 mm Hg), vasopressin + norepinephrine (vasopressin at fixed dose 0.01 U/minute plus norepinephrine titrated as for norepinephrine only group), or no vasopressor (Ringer's lactate [control]). Mean arterial pressure was well maintained in all treatment groups. Superior mesenteric arterial blood flow was significantly lower in the vasopressin + norepinephrine group than in the vasopressin group. Vasopressin alone or combined with norepinephrine limited the increase in blood lactate concentration and ileal PCO2-gap compared with control and norepinephrine groups. Urine output was higher in the vasopressin group than in control and norepinephrine groups. Survival time was longer in the vasopressin (30 +/- 6 hours) and vasopressin + norepinephrine (30 +/- 3 hours) groups than in the norepinephrine group (20 +/- 1 hours, p < 0.05) and in all treatment groups than in the control group (17 +/- 2 hours, p < 0.05). Tissue injury was less severe in the vasopressin and vasopressin + norepinephrine groups than in the others. In this clinically relevant model of septic shock due to peritonitis, vasopressin administration (alone or with norepinephrine) can prolong survival.</description><identifier>ISSN: 1073-449X</identifier><identifier>EISSN: 1535-4970</identifier><identifier>DOI: 10.1164/rccm.200205-447OC</identifier><identifier>PMID: 12791578</identifier><language>eng</language><publisher>United States: Am Thoracic Soc</publisher><subject>Animals ; Blood Pressure - drug effects ; Carbon Dioxide - blood ; Cecum - injuries ; Ileum - blood supply ; Intestinal Perforation - complications ; Isotonic Solutions ; Lactates - blood ; Mesenteric Arteries - drug effects ; Norepinephrine - administration & dosage ; Norepinephrine - therapeutic use ; Proportional Hazards Models ; Random Allocation ; Sheep ; Shock, Septic - drug therapy ; Shock, Septic - urine ; Splanchnic Circulation - drug effects ; Statistics, Nonparametric ; Survival Rate ; Vasoconstrictor Agents - administration & dosage ; Vasoconstrictor Agents - therapeutic use ; Vasopressins - administration & dosage ; Vasopressins - therapeutic use</subject><ispartof>American journal of respiratory and critical care medicine, 2003-08, Vol.168 (4), p.481-486</ispartof><rights>Copyright American Thoracic Society Aug 15, 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c358t-dfdc0f1d48234dcc59195d81649d0b340ce114208fad08551be680845918f6c3</citedby><cites>FETCH-LOGICAL-c358t-dfdc0f1d48234dcc59195d81649d0b340ce114208fad08551be680845918f6c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12791578$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sun, Qinghua</creatorcontrib><creatorcontrib>Dimopoulos, George</creatorcontrib><creatorcontrib>Nguyen, Duc Nam</creatorcontrib><creatorcontrib>Tu, Zizhi</creatorcontrib><creatorcontrib>Nagy, Nathalie</creatorcontrib><creatorcontrib>Hoang, Anh Dung</creatorcontrib><creatorcontrib>Rogiers, Peter</creatorcontrib><creatorcontrib>De Backer, Daniel</creatorcontrib><creatorcontrib>Vincent, Jean-Louis</creatorcontrib><title>Low-Dose Vasopressin in the Treatment of Septic Shock in Sheep</title><title>American journal of respiratory and critical care medicine</title><addtitle>Am J Respir Crit Care Med</addtitle><description>After induction of cecal perforation, 20 anesthetized sheep were randomized to be treated, when arterial blood pressure fell below 75 mm Hg, with vasopressin (fixed dose of 0.02 U/minute), norepinephrine (0.5-5 microg/kg/minute titrated to maintain mean arterial pressure between 75 and 85 mm Hg), vasopressin + norepinephrine (vasopressin at fixed dose 0.01 U/minute plus norepinephrine titrated as for norepinephrine only group), or no vasopressor (Ringer's lactate [control]). Mean arterial pressure was well maintained in all treatment groups. Superior mesenteric arterial blood flow was significantly lower in the vasopressin + norepinephrine group than in the vasopressin group. Vasopressin alone or combined with norepinephrine limited the increase in blood lactate concentration and ileal PCO2-gap compared with control and norepinephrine groups. Urine output was higher in the vasopressin group than in control and norepinephrine groups. Survival time was longer in the vasopressin (30 +/- 6 hours) and vasopressin + norepinephrine (30 +/- 3 hours) groups than in the norepinephrine group (20 +/- 1 hours, p < 0.05) and in all treatment groups than in the control group (17 +/- 2 hours, p < 0.05). Tissue injury was less severe in the vasopressin and vasopressin + norepinephrine groups than in the others. In this clinically relevant model of septic shock due to peritonitis, vasopressin administration (alone or with norepinephrine) can prolong survival.</description><subject>Animals</subject><subject>Blood Pressure - drug effects</subject><subject>Carbon Dioxide - blood</subject><subject>Cecum - injuries</subject><subject>Ileum - blood supply</subject><subject>Intestinal Perforation - complications</subject><subject>Isotonic Solutions</subject><subject>Lactates - blood</subject><subject>Mesenteric Arteries - drug effects</subject><subject>Norepinephrine - administration & dosage</subject><subject>Norepinephrine - therapeutic use</subject><subject>Proportional Hazards Models</subject><subject>Random Allocation</subject><subject>Sheep</subject><subject>Shock, Septic - drug therapy</subject><subject>Shock, Septic - urine</subject><subject>Splanchnic Circulation - drug effects</subject><subject>Statistics, Nonparametric</subject><subject>Survival Rate</subject><subject>Vasoconstrictor Agents - administration & dosage</subject><subject>Vasoconstrictor Agents - therapeutic use</subject><subject>Vasopressins - administration & dosage</subject><subject>Vasopressins - therapeutic use</subject><issn>1073-449X</issn><issn>1535-4970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNpdkF1LwzAUhoMobn78AG-keCF40ZnTJG16I8j8hMEuNsS70KWntrNtatIx_PdmdiAIgSTkOW_OeQi5ADoBiPmt1bqZRJRGVIScJ_PpARmDYP6SJvTQn2nC_EP6PiInzq0phUgCPSYjiJIURCLH5G5mtuGDcRi8Zc50Fp2r2sCvvsRgaTHrG2z7wBTBAru-0sGiNPpzByxKxO6MHBVZ7fB8v5-S5dPjcvoSzubPr9P7WaiZkH2YF7mmBeRcRoznWosUUpFLP0Oa0xXjVCMAj6gsspxKIWCFsaSSe04WsWan5HqI7az52qDrVVM5jXWdtWg2TiVMiIhz7sGrf-DabGzrW1OQprH_lcUeggHS1jhnsVCdrZrMfiugaidW7cSqQaz6FetrLvfBm1WD-V_F3qQHbgagrD7KbWVRuSara4-Dyta7QIil4opLYD8t9IDC</recordid><startdate>20030815</startdate><enddate>20030815</enddate><creator>Sun, Qinghua</creator><creator>Dimopoulos, George</creator><creator>Nguyen, Duc Nam</creator><creator>Tu, Zizhi</creator><creator>Nagy, Nathalie</creator><creator>Hoang, Anh Dung</creator><creator>Rogiers, Peter</creator><creator>De Backer, Daniel</creator><creator>Vincent, Jean-Louis</creator><general>Am Thoracic Soc</general><general>American Thoracic Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20030815</creationdate><title>Low-Dose Vasopressin in the Treatment of Septic Shock in Sheep</title><author>Sun, Qinghua ; Dimopoulos, George ; Nguyen, Duc Nam ; Tu, Zizhi ; Nagy, Nathalie ; Hoang, Anh Dung ; Rogiers, Peter ; De Backer, Daniel ; Vincent, Jean-Louis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c358t-dfdc0f1d48234dcc59195d81649d0b340ce114208fad08551be680845918f6c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Blood Pressure - drug effects</topic><topic>Carbon Dioxide - blood</topic><topic>Cecum - injuries</topic><topic>Ileum - blood supply</topic><topic>Intestinal Perforation - complications</topic><topic>Isotonic Solutions</topic><topic>Lactates - blood</topic><topic>Mesenteric Arteries - drug effects</topic><topic>Norepinephrine - administration & dosage</topic><topic>Norepinephrine - therapeutic use</topic><topic>Proportional Hazards Models</topic><topic>Random Allocation</topic><topic>Sheep</topic><topic>Shock, Septic - drug therapy</topic><topic>Shock, Septic - urine</topic><topic>Splanchnic Circulation - drug effects</topic><topic>Statistics, Nonparametric</topic><topic>Survival Rate</topic><topic>Vasoconstrictor Agents - administration & dosage</topic><topic>Vasoconstrictor Agents - therapeutic use</topic><topic>Vasopressins - administration & dosage</topic><topic>Vasopressins - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sun, Qinghua</creatorcontrib><creatorcontrib>Dimopoulos, George</creatorcontrib><creatorcontrib>Nguyen, Duc Nam</creatorcontrib><creatorcontrib>Tu, Zizhi</creatorcontrib><creatorcontrib>Nagy, Nathalie</creatorcontrib><creatorcontrib>Hoang, Anh Dung</creatorcontrib><creatorcontrib>Rogiers, Peter</creatorcontrib><creatorcontrib>De Backer, Daniel</creatorcontrib><creatorcontrib>Vincent, Jean-Louis</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of respiratory and critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sun, Qinghua</au><au>Dimopoulos, George</au><au>Nguyen, Duc Nam</au><au>Tu, Zizhi</au><au>Nagy, Nathalie</au><au>Hoang, Anh Dung</au><au>Rogiers, Peter</au><au>De Backer, Daniel</au><au>Vincent, Jean-Louis</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Low-Dose Vasopressin in the Treatment of Septic Shock in Sheep</atitle><jtitle>American journal of respiratory and critical care medicine</jtitle><addtitle>Am J Respir Crit Care Med</addtitle><date>2003-08-15</date><risdate>2003</risdate><volume>168</volume><issue>4</issue><spage>481</spage><epage>486</epage><pages>481-486</pages><issn>1073-449X</issn><eissn>1535-4970</eissn><abstract>After induction of cecal perforation, 20 anesthetized sheep were randomized to be treated, when arterial blood pressure fell below 75 mm Hg, with vasopressin (fixed dose of 0.02 U/minute), norepinephrine (0.5-5 microg/kg/minute titrated to maintain mean arterial pressure between 75 and 85 mm Hg), vasopressin + norepinephrine (vasopressin at fixed dose 0.01 U/minute plus norepinephrine titrated as for norepinephrine only group), or no vasopressor (Ringer's lactate [control]). Mean arterial pressure was well maintained in all treatment groups. Superior mesenteric arterial blood flow was significantly lower in the vasopressin + norepinephrine group than in the vasopressin group. Vasopressin alone or combined with norepinephrine limited the increase in blood lactate concentration and ileal PCO2-gap compared with control and norepinephrine groups. Urine output was higher in the vasopressin group than in control and norepinephrine groups. Survival time was longer in the vasopressin (30 +/- 6 hours) and vasopressin + norepinephrine (30 +/- 3 hours) groups than in the norepinephrine group (20 +/- 1 hours, p < 0.05) and in all treatment groups than in the control group (17 +/- 2 hours, p < 0.05). Tissue injury was less severe in the vasopressin and vasopressin + norepinephrine groups than in the others. In this clinically relevant model of septic shock due to peritonitis, vasopressin administration (alone or with norepinephrine) can prolong survival.</abstract><cop>United States</cop><pub>Am Thoracic Soc</pub><pmid>12791578</pmid><doi>10.1164/rccm.200205-447OC</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1073-449X |
ispartof | American journal of respiratory and critical care medicine, 2003-08, Vol.168 (4), p.481-486 |
issn | 1073-449X 1535-4970 |
language | eng |
recordid | cdi_proquest_miscellaneous_73552444 |
source | Freely Accessible Science Journals - May need to register for free articles; EZB Electronic Journals Library |
subjects | Animals Blood Pressure - drug effects Carbon Dioxide - blood Cecum - injuries Ileum - blood supply Intestinal Perforation - complications Isotonic Solutions Lactates - blood Mesenteric Arteries - drug effects Norepinephrine - administration & dosage Norepinephrine - therapeutic use Proportional Hazards Models Random Allocation Sheep Shock, Septic - drug therapy Shock, Septic - urine Splanchnic Circulation - drug effects Statistics, Nonparametric Survival Rate Vasoconstrictor Agents - administration & dosage Vasoconstrictor Agents - therapeutic use Vasopressins - administration & dosage Vasopressins - therapeutic use |
title | Low-Dose Vasopressin in the Treatment of Septic Shock in Sheep |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T23%3A38%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Low-Dose%20Vasopressin%20in%20the%20Treatment%20of%20Septic%20Shock%20in%20Sheep&rft.jtitle=American%20journal%20of%20respiratory%20and%20critical%20care%20medicine&rft.au=Sun,%20Qinghua&rft.date=2003-08-15&rft.volume=168&rft.issue=4&rft.spage=481&rft.epage=486&rft.pages=481-486&rft.issn=1073-449X&rft.eissn=1535-4970&rft_id=info:doi/10.1164/rccm.200205-447OC&rft_dat=%3Cproquest_cross%3E389399941%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c358t-dfdc0f1d48234dcc59195d81649d0b340ce114208fad08551be680845918f6c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=199619536&rft_id=info:pmid/12791578&rfr_iscdi=true |